|
|
Management Team
Martin Petkovich, PhD - Chief Scientific Officer
 |
Dr. Petkovich was a co-founder of Cytochroma Inc. and has provided scientific guidance as a full-time employee and currently as a consultant in the role of Chief Scientific Officer (CSO). Dr. Petkovich served as a Director of the Cytochroma until his appointment as CSO. Dr. Petkovich received his BSc from McMaster University in 1981 and PhD in Biochemistry in 1986 from the University of Toronto. He was a post-doctoral fellow in the laboratory of Dr. Pierre Chambon in Strasbourg, France from 1986 to 1989. He moved to Queen's University in 1990 to join the Departments of Biochemistry and Pathology and was appointed Full Professor in 1998. Dr. Petkovich is an expert in small molecule signaling, nuclear receptors and metabolism and much of his work since 1981 has focused on vitamins D and A. Dr. Petkovich discovered the fundamental mechanism of action of vitamin A by cloning the first receptor for the vitamin A metabolite, retinoic acid, and further went on to characterize a family of cytochrome P450 enzymes critical for modulating retinoic acid activity. These discoveries are cited as major breakthroughs in the vitamin A field. |
|
